Pittsburgh-based CytoAgents with Covid innovation starts clinical trials
CytoAgents, a Pittsburgh-based pharmaceutical company whose drug candidate battles a deadly side effect of respiratory illnesses like Covid-19, has reached the phase-one clinical trial stage. Read more >>